Home4503 • TYO
add
Astellas Pharma Inc
Nakaraang pagsara
¥1,682.00
Sakop ng araw
¥1,670.00 - ¥1,710.50
Sakop ng taon
¥1,426.00 - ¥2,168.00
Market cap
3.09T JPY
Average na Volume
6.21M
P/E ratio
143.98
Dividend yield
4.09%
Primary exchange
TYO
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 473.12B | 26.17% |
Gastos sa pagpapatakbo | 328.67B | 25.93% |
Net na kita | 37.60B | 13.50% |
Net profit margin | 7.95 | -9.97% |
Kita sa bawat share | — | — |
EBITDA | 103.59B | 51.67% |
Aktuwal na % ng binabayarang buwis | 25.53% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 302.93B | -46.05% |
Kabuuang asset | 3.74T | 33.51% |
Kabuuang sagutin | 2.06T | 68.84% |
Kabuuang equity | 1.68T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 1.80 | — |
Return on assets | 3.65% | — |
Return on capital | 5.14% | — |
Cash Flow
Net change in cash
| (JPY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 37.60B | 13.50% |
Cash mula sa mga operasyon | 12.60B | 3.30% |
Cash mula sa pag-invest | -39.35B | -219.91% |
Cash mula sa financing | -11.92B | -107.22% |
Net change in cash | -32.76B | -117.74% |
Malayang cash flow | -10.77B | -238.22% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
14,754
